Log in

BATS:RSXVanEck Vectors Russia ETF Stock Price, Forecast & News

$21.81
+0.28 (+1.30 %)
(As of 06/4/2020 03:53 AM ET)
Add
Today's Range
$21.54
Now: $21.81
$21.88
50-Day Range
$17.15
MA: $19.22
$21.43
52-Week Range N/A
Volume5.53 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Basic Details

Issuer Van Eck
Fund NameVanEck Vectors Russia ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:RSX
Inception Date4/24/2007
Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkMVIS Russia Index
CategoryBroad Equity
FocusBroad Equity
Development LevelEmerging Markets
RegionEurope

Fund Statistics

Assets Under Management$985.48 million
Average Daily Volume$4.65 million
Discount/Premium0.04%

ETF Expenses

Management Fee0.50%
Other Expenses0.15%
Total Expenses0.65%
Fee Waiver-0.15%
Net Expenses0.65%

Administrator, Advisor and Custodian

AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianState Street Bank and Trust Company
DistributorVan Eck Securities Corporation
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market Maker

Receive RSX News and Ratings via Email

Sign-up to receive the latest news and ratings for RSX and its competitors with MarketBeat's FREE daily newsletter.

Geographic Exposure of VanEck Vectors Russia ETF (BATS:RSX)
Currency Exposure of VanEck Vectors Russia ETF (BATS:RSX)
Sector Exposure of VanEck Vectors Russia ETF (BATS:RSX)
Industry Exposure of VanEck Vectors Russia ETF (BATS:RSX)

VanEck Vectors Russia ETF (BATS:RSX) Frequently Asked Questions

How has VanEck Vectors Russia ETF's stock been impacted by COVID-19 (Coronavirus)?

VanEck Vectors Russia ETF's stock was trading at $17.71 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, RSX stock has increased by 23.2% and is now trading at $21.81. View which stocks have been most impacted by Coronavirus.

Has VanEck Vectors Russia ETF been receiving favorable news coverage?

Media headlines about RSX stock have trended very negative recently, according to InfoTrie. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. VanEck Vectors Russia ETF earned a news impact score of -3.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutVanEck Vectors Russia ETF.

What other stocks do shareholders of VanEck Vectors Russia ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Russia ETF investors own include Archer Daniels Midland (ADM), Citigroup (C), Discover Financial Services (DFS), Enterprise Products Partners (EPD), Energy Transfer LP Unit (ET), Aecom (ACM), AbbVie (ABBV), Activision Blizzard (ATVI), Applied Materials (AMAT) and Alexion Pharmaceuticals (ALXN).

What is VanEck Vectors Russia ETF's stock symbol?

VanEck Vectors Russia ETF trades on the BATS under the ticker symbol "RSX."

How do I buy shares of VanEck Vectors Russia ETF?

Shares of RSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is VanEck Vectors Russia ETF's stock price today?

One share of RSX stock can currently be purchased for approximately $21.81.

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.